EARLY DISEASE INTERVENTION
Technological platform for the assistance of diagnosis,
screening and monitoring of chronic conditions across multiple organs
DIAGNOSIS
Non-invasive disease detection means earlier diagnosis and earlier intervention for better patient outcomes.
SCREENING
Risk stratification among large patient populations allows for better management leading to cost reductions.
MONITORING
Regular surveillance with easily repeatable non-invasive diagnostics enables optimized disease management.
Comprehensive range of clinical technology
Broad range of products built with artificial intelligence technology to aid in disease management while reducing costs and improving outcomes
Trusted by healthcare professionals
Client’s contentment is of paramount importance to us
Take a look at what our clients have to say about our non-invasive clinical technology
An opportunity for us to consider working together just surfaced. A sponsor of ours is seeking our help to identify a test that could be used on site to increase the enrolment of patients suffering of NASH. Currently, the local community centers are not equipped or proficient in this disease area and would like to access a test that could be used as a pre-screen to enriched the target population. Blinded Diagnostics
Pappas Health has used the LIVERFASt test as a new addition to our practice, to provide further insight into our patients liver and overall health. We see it as an important addition to providing overall care and have been pleased with its performance and results so far Pappas Health
Liver disease is a silent killer with millions of Americans at potential risk. The strategy that Fibronostics is using to quickly assess a patient for the likelihood or existence of liver disease is badly needed. If their plan to reach the liver disease market with an effective and easily administered test is successful, they will make a significant contribution to the process of identification and treatment of liver disease. Fatty Liver Foundation
Previous
Next
2000
+
Patients Screened
With LIVERFASt
2000
+
Patients Tested
With LIVERFASt select
100
+
Doctors
use our Daily test
Partnerships
Working with diverse healthcare industry leaders
